v3.25.1
Statements of Changes in Stockholders' Deficiency Equity - CAD ($)
Issued capital [member]
Equity Portion Of Convertible Debentures Reserve [Member]
Warrant reserve [member]
Options [Member]
Share Subscription [Member]
Retained earnings [member]
Total
Beginning balance, value at Dec. 31, 2023 $ 27,736,269 $ 33,706 $ 24,000 $ (28,141,037) $ (620,062)
Beginning balance, shares at Dec. 31, 2023 13,745,947            
IfrsStatementLineItems [Line Items]              
Net loss for the period (68,295) (68,295)
Shares Subscription received 9,000 9,000
Share-based payment 50,265 50,265
Ending balance, shares at Mar. 31, 2024 13,745,947            
Ending balance, value at Mar. 31, 2024 $ 27,736,269 33,706 24,000 50,265 9,000 (28,482,332) (629,092)
IfrsStatementLineItems [Line Items]              
Net loss for the period   (140,698) (140,698)
Share-based payment 41,423 41,423
Ending balance, shares at Dec. 31, 2024 15,205,947            
IfrsStatementLineItems [Line Items]              
Private placement, net of issuance of costs $ 120,343 24,157 (9,000) 135,500
Private placement, net of issuance of costs, shares 1,460,000            
Ending balance, value at Dec. 31, 2024 $ 27,856,612 33,706 48,157 91,688 (28,623,030) (592,867)
IfrsStatementLineItems [Line Items]              
Net loss for the period (25,505) (25,505)
Share-based payment 7,410 7,410
Ending balance, shares at Mar. 31, 2025 15,205,947            
Ending balance, value at Mar. 31, 2025 $ 27,856,612 $ 33,706 $ 48,157 $ 99,098 $ (28,648,535) $ (610,962)